Sections
Highlight
Sections
Highlight
Ángel Escalera
MALAGA.
Friday, 16 December 2022, 15:12
Research is essential in the fight against cancer and two new projects are to be carried out in Malaga, at the Clínico Virgen de la Victoria and Regional hospitals. Led by Dr Elisa Matas and Dr Alexandra Cantero, the research has received 437,000 euros of funding from the Spanish Association Against Cancer (AECC) to try to achieve greater effectiveness in immunotherapy for bladder and lung tumours.
Elisa Matas, a researcher at the Biomedicine Research Institute of Malaga and Nanomedicine Platform and at Malaga university, is working on a new strategy for treating aggressive tumours which have begun to invade the muscle layer of the bladder, as in these cases the treatment options are drastically reduced.
At present, the usual treatment is surgery and chemotherapy, and the percentage of positive results from immunotherapy is very low (around 20%) and the benefits are not longlasting.
“We are looking for a way to boost the immune system so patients respond better to this type of therapy,” Dr Matas told SUR.
The other research project, led by Dr Alexandra Cantero, will investigate which patients with lung cancer will benefit from immunotherapy and who will not and will be based on liquid biopsy, a technique developed only a few years ago which is now being used in all hospitals and which provides information about a solid tumour from a sample of liquids, in this case blood.
It will analyse a group of genes from the sample which are related to the development of a tumour. “My project will use artificial intelligence to see what role the variables in these genes play, especially in the response to immunotherapy as a treatment for lung cancer. I want to be able to find out which patients it will suit and which it won’t, before the treatment begins,” she explained.
The two research projects will last for three years or possibly be extended for a fourth year, depending on progress.
Publicidad
Publicidad
Publicidad
Publicidad
Esta funcionalidad es exclusiva para registrados.
Reporta un error en esta noticia
Debido a un error no hemos podido dar de alta tu suscripción.
Por favor, ponte en contacto con Atención al Cliente.
¡Bienvenido a SURINENGLISH!
Tu suscripción con Google se ha realizado correctamente, pero ya tenías otra suscripción activa en SURINENGLISH.
Déjanos tus datos y nos pondremos en contacto contigo para analizar tu caso
¡Tu suscripción con Google se ha realizado correctamente!
La compra se ha asociado al siguiente email
Comentar es una ventaja exclusiva para registrados
¿Ya eres registrado?
Inicia sesiónNecesitas ser suscriptor para poder votar.